ArticleNeurology(R) neuroimmunology & neuroinflammation2016

Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cells.

Maija Saraste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.